ClinicalTrialsFinder
RecruitingNCT04212910

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Sponsor

IRCCS San Raffaele

Enrollment

101 participants

Start Date

Jul 23, 2019

Study Type

OBSERVATIONAL

Conditions

Endometrium Cancer

Summary

Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • histopathological confirmation of a primary endometrial cancer
  • age \> 18 years
  • no contraindication to surgery (comorbidity, contraindication or lack of consent)
  • no contraindication to preoperative imaging
  • visible tumor at imaging
  • signed inform consent.

Exclusion Criteria4

  • patients unsuitable for surgical intervention (comorbidity, contraindication or lack of consent, poor performance status)
  • age \< 18 years, c) inability to complete the needed imaging examination (ie, severe claustrophobia)
  • any additional medical condition that may significantly interfere with study compliance
  • all the contraindication for MRI (ie, pacemaker).

Locations(1)

IRCCS Ospedale San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04212910

Related Trials

Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

NCT073187271 location

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT0590298814 locations

Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

NCT061694491 location

A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.

NCT068416531 location

Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study

NCT040145301 location